Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.31

(-2.24%)

Long Term Debt Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual long term debt in 2023 was 722.97 Million USD , down -6.52% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly long term debt in 2024 Q1 was 643.64 Million USD , down -13.25% from previous quarter.
  • Curaleaf Holdings, Inc. reported annual long term debt of 773.38 Million USD in 2022, up 33.71% from previous year.
  • Curaleaf Holdings, Inc. reported annual long term debt of 578.41 Million USD in 2021, up 59.3% from previous year.
  • Curaleaf Holdings, Inc. reported quarterly long term debt of 724.86 Million USD for 2024 Q2, down -3.22% from previous quarter.
  • Curaleaf Holdings, Inc. reported quarterly long term debt of 722.97 Million USD for 2023 FY, down -6.52% from previous quarter.

Annual Long Term Debt Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Historical Annual Long Term Debt of Curaleaf Holdings, Inc. (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 722.97 Million USD -6.52%
2022 773.38 Million USD 33.71%
2021 578.41 Million USD 59.3%
2020 363.09 Million USD 218.35%
2019 114.05 Million CAD 1.96%
2018 111.86 Million CAD 775.79%
2017 12.77 Million CAD 0.0%
2016 - CAD 0.0%

Peer Long Term Debt Comparison of Curaleaf Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
Aurora Cannabis Inc. 47.57 Million CAD -1419.683%
Avicanna Inc. 95.36 Thousand CAD -758036.234%
Avant Brands Inc. 1.74 Million CAD -41426.357%
Cardiol Therapeutics Inc. 158.53 Thousand CAD -455942.865%
Crescita Therapeutics Inc. 815 Thousand CAD -88608.451%
Knight Therapeutics Inc. 44.01 Million CAD -1542.525%
MediPharm Labs Corp. 69 Thousand CAD -1047688.225%
OrganiGram Holdings Inc. 79 Thousand CAD -915056.804%
Canopy Growth Corporation 493.29 Million CAD -46.56%
Willow Biosciences Inc. 594 Thousand CAD -121612.774%
Auxly Cannabis Group Inc. 81.38 Million CAD -788.36%